Baseline risk of recurrence in stage I-II endometrial carcinoma.

ABSTRACT:

Objective

Though there are no evidences that postoperative therapy improves overall survival (OS) in stage I-II endometrial carcinoma, many women receive postoperative radiation or chemotherapy. This study aimed to investigate the baseline risk of recurrence after complete resection without any adjuvant therapies and to suppose the validity of postoperative therapy for stage I-II endometrial carcinoma.

Methods

Charts for patients with stage I-II endometrial carcinoma who underwent operation without postoperative therapy between January 2005 and December 2011 were retrospectively reviewed and the baseline risk of recurrence and prognosis were assessed. Risk classifications were performed according to European Society for Medical Oncology (ESMO) clinical practice guidelines an

SUBMITTER: Sasada S 

PROVIDER: S-EPMC5709535 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature